Table 5.
Lymph Node Dissection | No Lymph Node Dissection |
P | ||
---|---|---|---|---|
N | 202 | 202 | ||
Mean Age (Years, SD) | 54.08 (15.14) | 55.54 (14.83) | 0.3 | |
Race [N (%)] | 0.6 | |||
White | 185 (91.6) | 187 (92.6) | ||
African-America | 10 (5.0) | 11 (5.4) | ||
Other | 7 (3.5) | 4 (2.0) | ||
Period of Diagnosis [N (%)] | 0.3 | |||
2003–2005 | 87 (43.1) | 81 (40.1) | ||
2006–2008 | 54 (26.7) | 68 (33.7) | ||
2009–2011 | 61 (30.2) | 53 (26.2) | ||
Facility Type [N (%)] | 0.8 | |||
Academic | 91 (45.0) | 96 (47.5) | ||
Community | 10 (5.0) | 9 (4.5) | ||
Comprehensive | 101 (50.0) | 97 (48.0) | ||
Urban vs. Rural [N (%)] | 0.8 | |||
Urban | 188 (93.1) | 188 (93.1) | ||
Rural | 2 (1.0) | 3 (1.5) | ||
Unknown | 12 (5.9) | 11 (5.4) | ||
Registry Location [N (%)] | 0.9 | |||
Northeast | 40 (19.8) | 37 (18.3) | ||
Midwest | 46 (22.8) | 50 (24.8) | ||
South | 93 (46.0) | 89 (44.1) | ||
West | 23 (11.4) | 26 (12.9) | ||
Income [N (%)] | 0.9 | |||
1st Quartile | 26 (12.9) | 25 (12.4) | ||
2nd Quartile | 53 (26.2) | 56 (27.7) | ||
3rd Quartile | 58 (28.7) | 59 (29.2) | ||
4th Quartile | 59 (29.2) | 55 (27.2) | ||
Unknown | 6 (3.0) | 7 (3.5) | ||
Insurance [N (%)] | 0.9 | |||
None | 17 (8.4) | 15 (7.4%) | ||
Private | 111 (55.0) | 111 (55.0%) | ||
Medicare | 50 (24.8) | 54 (26.7%) | ||
Other Government | 16 (7.9) | 17 (8.4%) | ||
Unknown | 8 (4.0) | 5 (2.5%) | ||
Charlson/Deyo Score [N (%)] |
0.7 | |||
0 | 167 (82.7) | 168 (83.2) | ||
1 | 31 (15.3) | 28 (13.9) | ||
2 | 4 (2.0) | 6 (3.0) | ||
Education Level [N (%)] | 0.7 | |||
<7% | 48 (23.8) | 46 (22.8) | ||
7–13% | 75 (37.1) | 65 (32.2) | ||
13–21% | 48 (23.8) | 53 (26.2) | ||
>21% | 25 (12.4) | 31 (15.3) | ||
Unknown | 6 (3.0) | 7 (3.5) | ||
Stage [N (%)] | 171 (84.7) | 165 (81.7) | ||
IIIC | 31 (15.3) | 37 (18.3) | ||
IV | ||||
Tumor size [N (%)] | 0.7 | |||
<1cm | 4 (2.0) | 2 (1.0) | ||
<2cm | 9 (4.5) | 9 (4.5) | ||
<3cm | 10 (5.0) | 6 (3.0) | ||
<4cm | 5 (2.5) | 4 (2.0) | ||
<5cm | 12 (5.9) | 8 (4.0) | ||
> 5cm | 95 (47.0) | 98 (48.5) |
SD: Standard Deviation.